High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study

  • Christopher J. Ryerson
    Department of Medicine
  • Pat G. Camp
    Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada
  • Neil D. Eves
    Centre for Heart, Lung and Vascular Health, University of British Columbia, Kelowna, British Columbia, Canada
  • Michele Schaeffer
    Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada
  • Nafeez Syed
    Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada
  • Satvir Dhillon
    Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada
  • Dennis Jensen
    Department of Kinesiology and Physical Education, McGill University; Division of Respiratory Medicine, Department of Medicine, McGill University and Research Institute of the McGill University Health Centre; and Centre for Innovative Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
  • Francois Maltais
    Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, Quebec, Canada
  • Denis E. O’Donnell
    Division of Respiratory and Critical Care Medicine, Queen’s University, Kingston, Ontario, Canada
  • Natya Raghavan
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • Michael Roman
    Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
  • Michael K. Stickland
    Pulmonary Division, Department of Medicine, University of Alberta and G. F. MacDonald Centre for Lung Health, Covenant Health, Edmonton, Alberta, Canada
  • Deborah Assayag
    Department of Medicine, McGill University, Montreal, Quebec, Canada
  • Jean Bourbeau
    Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada
  • Genevieve Dion
    Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, Quebec, Canada
  • Charlene D. Fell
    Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
  • Nathan Hambly
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • Kerri A. Johannson
    Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
  • Meena Kalluri
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • Nasreen Khalil
    Department of Medicine
  • Martin Kolb
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • Helene Manganas
    Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada; and
  • Onofre Morán-Mendoza
    Division of Respiratory and Critical Care Medicine, Queen’s University, Kingston, Ontario, Canada
  • Steve Provencher
    Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, Quebec, Canada
  • Warren Ramesh
    Royal Alexandra Hospital, Edmonton, Alberta, Canada
  • J. Douglass Rolf
    Department of Medicine
  • Pearce G. Wilcox
    Department of Medicine
  • Jordan A. Guenette
    Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada

この論文をさがす

収録刊行物

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ